---
figid: PMC5685854__WJG-23-7478-g007
figlink: /pmc/articles/PMC5685854/figure/F7/
number: F7
caption: 'Pathway of VEGFR-2 (produced using the Pathway Builder Tool). Bevacizumab
  targets VEGF-A to prevent its interaction with VEGFR-2; apatinib mainly targets
  VEGFR-2. VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial growth
  factor receptor.'
pmcid: PMC5685854
papertitle: 'Extraordinary response of metastatic pancreatic cancer to apatinib after
  failed chemotherapy: A case report and literature review.'
reftext: Cheng-Ming Li, et al. World J Gastroenterol. 2017 Nov 7;23(41):7478-7488.
pmc_ranked_result_index: '23287'
pathway_score: 0.9357203
filename: WJG-23-7478-g007.jpg
figtitle: Pathway of VEGFR-2 (produced using the Pathway Builder Tool)
year: '2017'
organisms:
- Homo sapiens
ndex: 667b23f1-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5685854__WJG-23-7478-g007.html
  '@type': Dataset
  description: 'Pathway of VEGFR-2 (produced using the Pathway Builder Tool). Bevacizumab
    targets VEGF-A to prevent its interaction with VEGFR-2; apatinib mainly targets
    VEGFR-2. VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial
    growth factor receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3R6
  - PIK3CA
  - PIK3R4
  - PIK3CD
  - VEGFC
  - PIK3R5
  - HRAS
  - VEGFA
  - PTK2
  - PXN
  - MAPK3
  - KRAS
  - NRAS
  - SRC
  - PIK3R3
  - VEGFD
  - KDR
  - MAPK1
  - PIK3CG
  - ACDP
  - Apatinib
  - Cancer
genes:
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: VEGF-C
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: PXN
  symbol: PXN
  source: hgnc_symbol
  hgnc_symbol: PXN
  entrez: '5829'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGF-D
  symbol: VEGF-D
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: P13K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals:
- word: ACDP
  source: MESH
  identifier: C067723
- word: Apatinib
  source: MESH
  identifier: C553458
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5685854__F7
redirect_from: /figures/PMC5685854__F7
figtype: Figure
---
